Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
oxaliplatin + paclitaxel
- Development stage
- Unknown
- Lead developer
- Sanofi
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Oxaliplatin + paclitaxel is a combination of two chemotherapeutic agents used in the treatment of various cancers. Oxaliplatin is a platinum-based chemotherapy drug that exerts its antitumor effects primarily by forming DNA crosslinks, leading to inhibition of DNA replication and transcription, ultimately resulting in cell death. It also binds to mitochondrial DNA and disrupts mitochondrial function, contributing to cytotoxicity[3][6]. Paclitaxel is a microtubule-stabilizing agent that prevents the disassembly of microtubules during cell division, causing mitotic arrest and apoptosis in cancer cells[1][4][6]. This combination may be used off-label or within clinical trials for certain solid tumors where synergistic effects are desired.
- Brand names
- Eloxatin
- Other names
- None
02
Targets
Microtubule
Beyond the preview
Go deeper on oxaliplatin + paclitaxel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on oxaliplatin + paclitaxel.